Insider Transactions in Q4 2020 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
Jay R. Luly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,201
-0.32%
|
$92,442
$42.52 P/Share
|
|
Dec 15
2020
|
Jay R. Luly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+1.09%
|
-
|
|
Dec 15
2020
|
Yat Sun Or Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,540
-0.48%
|
$64,680
$42.52 P/Share
|
|
Dec 15
2020
|
Yat Sun Or Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,250
+1.62%
|
-
|
|
Dec 15
2020
|
Nathalie Adda Sr. VP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,540
-5.41%
|
$64,680
$42.52 P/Share
|
|
Dec 15
2020
|
Nathalie Adda Sr. VP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,250
+15.56%
|
-
|
|
Dec 15
2020
|
Paul J Mellett Chief Fin. & Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
770
-1.36%
|
$32,340
$42.52 P/Share
|
|
Dec 15
2020
|
Paul J Mellett Chief Fin. & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,625
+4.44%
|
-
|
|
Dec 15
2020
|
Nathaniel S. Gardiner Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,540
-3.52%
|
$64,680
$42.52 P/Share
|
|
Dec 15
2020
|
Nathaniel S. Gardiner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,250
+10.71%
|
-
|
|
Dec 03
2020
|
Nathaniel S. Gardiner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+4.15%
|
$50,010
$30.0 P/Share
|
|
Nov 20
2020
|
Jay R. Luly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,500
+3.77%
|
-
|
|
Nov 20
2020
|
Paul J Mellett Chief Fin. & Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,600
+12.36%
|
-
|
|
Nov 20
2020
|
Yat Sun Or Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,600
+2.37%
|
-
|
|
Nov 20
2020
|
Nathalie Adda Sr. VP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,600
+24.65%
|
-
|
|
Nov 20
2020
|
Nathaniel S. Gardiner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,600
+17.09%
|
-
|
|
Nov 11
2020
|
Paul J Mellett Chief Fin. & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,480
+6.99%
|
$6,960
$2.54 P/Share
|